These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27216408)

  • 1. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014.
    Khin HS; Aung T; Thi A; White C;
    Malar J; 2016 May; 15(1):286. PubMed ID: 27216408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who continues to stock oral artemisinin monotherapy? Results of a provider survey in Myanmar.
    Thein ST; Sudhinaraset M; Khin HS; McFarland W; Aung T
    Malar J; 2016 Jun; 15():334. PubMed ID: 27333781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using supply side evidence to inform oral artemisinin monotherapy replacement in Myanmar: a case study.
    Khin HS; Aung T; Aung M; Thi A; Boxshall M; ; White C
    Malar J; 2016 Aug; 15(1):418. PubMed ID: 27538783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016.
    ; Thein ST; Khin HSS; Thi A
    Malar J; 2017 Apr; 16(1):129. PubMed ID: 28438197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention.
    Khin HS; Chen I; White C; Sudhinaraset M; McFarland W; Littrell M; Montagu D; Aung T
    Malar J; 2015 Jul; 14():269. PubMed ID: 26169498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey.
    ; Thein ST; Khin HSS; Thi A
    Malar J; 2017 Apr; 16(1):170. PubMed ID: 28438145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The malaria testing and treatment landscape in Benin.
    ; Zinsou C; Cherifath AB
    Malar J; 2017 Apr; 16(1):174. PubMed ID: 28446236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
    O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
    Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
    ; Mpanya G; Tshefu A; Likwela JL
    Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malaria testing and treatment landscape in mainland Tanzania, 2016.
    ; Michael D; Mkunde SP
    Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys.
    ; Novotny J; Singh A; Dysoley L; Sovannaroth S; Rekol H
    Malar J; 2016 Apr; 15():194. PubMed ID: 27059952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
    ; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
    Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.
    ; Phok S; Phanalasy S; Thein ST; Likhitsup A
    Malar J; 2017 May; 16(1):180. PubMed ID: 28464945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.
    Littrell M; Gatakaa H; Phok S; Allen H; Yeung S; Chuor CM; Dysoley L; Socheat D; Spiers A; White C; Shewchuk T; Chavasse D; O'Connell KA
    Malar J; 2011 Oct; 10():328. PubMed ID: 22039922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress.
    ; Ujuju C; Anyanti J; Newton PN; Ntadom G
    Malar J; 2017 Dec; 16(1):489. PubMed ID: 29246208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.
    Ocan M; Nambatya W; Otike C; Nakalembe L; Nsobya S
    PLoS One; 2024; 19(3):e0295198. PubMed ID: 38536824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Private sector role, readiness and performance for malaria case management in Uganda, 2015.
    ; Kaula H; Buyungo P; Opigo J
    Malar J; 2017 May; 16(1):219. PubMed ID: 28545583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.
    ; Phok S; Lek D
    Malar J; 2017 Apr; 16(1):171. PubMed ID: 28438204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys.
    Edwards HM; Sarwar R; Mahmud P; Emmanuel S; Maxwell K; Tibenderana JK
    Malar J; 2022 Feb; 21(1):42. PubMed ID: 35151332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
    Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
    Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.